大行評級|高盛:維持人保H股“買入”評級 目標價3.5港元
高盛發報吿指,維持對中國人民保險集團H股目標價3.5港元,維持“買入”評級;但A股目標價從3.1元上調至3.3元,維持“沽售”評級,主要反映較高賬面值,及對最新人民幣兑港元的匯率調整至1.07,而此前為1.11。
高盛指,下調對該公司2023年下半年淨利潤預測85%,主要原因是與自然災害相關的索賠高於預期,以及投資回報低於預期。根據新會計準則,對股票市場的利潤敏感度有所增加,鑑於迄今為止疲軟的股票市場,預計第四季度將面臨更多阻力。這導致高盛對該公司2023財年淨利預測下調24%。展望未來,高盛下調中國人保集團2024和2025財年盈測7%和3%,不過上調2023-2025財年股東權益預測上調4-9%,主要反映新會計準則的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.